Last rites for the first glitazone
Executive Summary
FDA withdraws approval for NDA for Pfizer's Rezulin (troglitazone), a notice in the Jan. 10 Federal Register states. Pfizer withdrew the NDA for the diabetes drug after the product was pulled from the market in 2000 following 90 cases of acute liver damage, including 63 deaths (1"The Pink Sheet" March 27, 2000, p. 4)...